This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2015 Apr;12(2):110-2.

doi: 10.1177/1740774514568875. Epub 2015 Feb 3.

Commentary on Hey and Kimmelman

J Jack Lee¹

Affiliations

PMID: 25649110
PMCID: PMC4492278
DOI: 10.1177/1740774514568875

Comment

Commentary on Hey and Kimmelman

J Jack Lee. Clin Trials. 2015 Apr.

. 2015 Apr;12(2):110-2.

doi: 10.1177/1740774514568875. Epub 2015 Feb 3.

Author

J Jack Lee¹

Affiliation

¹ Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA jjlee@mdanderson.org.

PMID: 25649110
PMCID: PMC4492278
DOI: 10.1177/1740774514568875

No abstract available

PubMed Disclaimer

Conflict of interest statement

Declaration of conflicting interests

No conflict of interests.

Comment on

Are outcome-adaptive allocation trials ethical?
Hey SP, Kimmelman J. Hey SP, et al. Clin Trials. 2015 Apr;12(2):102-6. doi: 10.1177/1740774514563583. Epub 2015 Feb 3. Clin Trials. 2015. PMID: 25649106 Free PMC article.

Similar articles

Commentary on Hey and Kimmelman.
Joffe S, Ellenberg SS. Joffe S, et al. Clin Trials. 2015 Apr;12(2):116-8. doi: 10.1177/1740774515568917. Epub 2015 Feb 3. Clin Trials. 2015. PMID: 25649113 No abstract available.
Commentary on Hey and Kimmelman.
Buyse M. Buyse M. Clin Trials. 2015 Apr;12(2):119-21. doi: 10.1177/1740774515568916. Epub 2015 Feb 3. Clin Trials. 2015. PMID: 25649112 No abstract available.
Commentary on Hey and Kimmelman.
Berry DA. Berry DA. Clin Trials. 2015 Apr;12(2):107-9. doi: 10.1177/1740774515569011. Epub 2015 Feb 3. Clin Trials. 2015. PMID: 25649111 No abstract available.
Data withdrawal in randomized controlled trials: Defining the problem and proposing solutions: a commentary.
Ye C, Giangregorio L, Holbrook A, Pullenayegum E, Goldsmith CH, Thabane L. Ye C, et al. Contemp Clin Trials. 2011 May;32(3):318-22. doi: 10.1016/j.cct.2011.01.016. Epub 2011 Feb 4. Contemp Clin Trials. 2011. PMID: 21300179 Review.
Design of randomized controlled trials.
Stanley K. Stanley K. Circulation. 2007 Mar 6;115(9):1164-9. doi: 10.1161/CIRCULATIONAHA.105.594945. Circulation. 2007. PMID: 17339574 Review. No abstract available.

See all similar articles

Cited by

A post hoc evaluation of a sample size re-estimation in the Secondary Prevention of Small Subcortical Strokes study.
McClure LA, Szychowski JM, Benavente O, Hart RG, Coffey CS. McClure LA, et al. Clin Trials. 2016 Oct;13(5):537-44. doi: 10.1177/1740774516643689. Epub 2016 Apr 19. Clin Trials. 2016. PMID: 27094488 Free PMC article.
Adaptive Clinical Trials: Advantages and Disadvantages of Various Adaptive Design Elements.
Korn EL, Freidlin B. Korn EL, et al. J Natl Cancer Inst. 2017 Jun 1;109(6):djx013. doi: 10.1093/jnci/djx013. J Natl Cancer Inst. 2017. PMID: 28376148 Free PMC article.
A conceptual model for the development process of confirmatory adaptive clinical trials within an emergency research network.
Mawocha SC, Fetters MD, Legocki LJ, Guetterman TC, Frederiksen S, Barsan WG, Lewis RJ, Berry DA, Meurer WJ. Mawocha SC, et al. Clin Trials. 2017 Jun;14(3):246-254. doi: 10.1177/1740774516688900. Epub 2017 Jan 31. Clin Trials. 2017. PMID: 28135827 Free PMC article.
A Bayesian adaptive randomized phase II multicenter trial of bevacizumab with or without vorinostat in adults with recurrent glioblastoma.
Puduvalli VK, Wu J, Yuan Y, Armstrong TS, Vera E, Wu J, Xu J, Giglio P, Colman H, Walbert T, Raizer J, Groves MD, Tran D, Iwamoto F, Avgeropoulos N, Paleologos N, Fink K, Peereboom D, Chamberlain M, Merrell R, Penas Prado M, Yung WKA, Gilbert MR. Puduvalli VK, et al. Neuro Oncol. 2020 Oct 14;22(10):1505-1515. doi: 10.1093/neuonc/noaa062. Neuro Oncol. 2020. PMID: 32166308 Free PMC article. Clinical Trial.
Outcome-adaptive randomization in clinical trials: issues of participant welfare and autonomy.
Sim J. Sim J. Theor Med Bioeth. 2019 Apr;40(2):83-101. doi: 10.1007/s11017-019-09481-0. Theor Med Bioeth. 2019. PMID: 30778720 Free PMC article.

See all "Cited by" articles

References

1. Hu F, Rosenberger WF. The theory of response-adaptive randomization in clinical trials. Hoboken, New Jersey: John Wiley & Sons, Inc; 2006.
1. Korn EL, Freidlin B. Outcome-adaptive randomization: Is it useful? J Clin Oncol. 2011;29:771–776. - PMC - PubMed
1. Lee JJ, Chen N, Yin G. Worth adapting? Revisiting the usefulness of outcome-adaptive randomization. Clin Cancer Res. 2012;18:4498–4507. - PMC - PubMed
1. Du Y, Wang X, Lee JJ. Simulation study for evaluating the performance of response-adaptive randomization. Contemp Clin Trials. 2014;40C:15–25. - PMC - PubMed
1. Berry DA, Eick SG. Adaptive assignment versus balanced randomization in clinical trials: a decision analysis. Stat Med. 1995;14:231–246. - PubMed

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions

Grants and funding

LinkOut - more resources

Full Text Sources
Other Literature Sources
- scite Smart Citations